First international TNBC conference meeting report

Padmashree Rida, Angela Ogden, Ian O. Ellis, Zsuzsanna Varga, Antonio C. Wolff, Tiffany A. Traina, Christos Hatzis, Julie R. Palmer, Christine B. Ambrosone, Brian D. Lehmann, Rita Nanda, Valerie Montgomery Rice, Otis W. Brawley, Mylin A. Torres, Emad Rakha, Ritu Aneja

Research output: Contribution to journalReview article

Abstract

Recently, Georgia State University’s Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders.

Original languageEnglish (US)
Pages (from-to)407-412
Number of pages6
JournalBreast Cancer Research and Treatment
Volume169
Issue number3
DOIs
StatePublished - Jun 1 2018

    Fingerprint

Keywords

  • Immunotherapy
  • Molecular subtypes
  • Racial disparities
  • Targeted drugs
  • Triple negative breast cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Rida, P., Ogden, A., Ellis, I. O., Varga, Z., Wolff, A. C., Traina, T. A., Hatzis, C., Palmer, J. R., Ambrosone, C. B., Lehmann, B. D., Nanda, R., Montgomery Rice, V., Brawley, O. W., Torres, M. A., Rakha, E., & Aneja, R. (2018). First international TNBC conference meeting report. Breast Cancer Research and Treatment, 169(3), 407-412. https://doi.org/10.1007/s10549-018-4692-3